SEC Form 4 · accession 0001179110-18-006062
Teladoc Health, Inc. · TDOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Hirschhorn
Officer — Executive VP, COO and CFO
Period of report
Apr 30, 2018
Accepted (ET)
May 2, 2018 · 5:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001477449
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 30, 2018 | M | 1,579 | $6.01 | A | 50,042 | D | |
| Common Stock | Apr 30, 2018 | M | 705 | $6.01 | A | 50,747 | D | |
| Common Stock | Apr 30, 2018 | M | 6,264 | $22.30 | A | 57,011 | D | |
| Common StockF3,F4 | May 1, 2018 | S | 40,000 | $42.67 | D | 17,011 | D | |
| Common Stock | May 2, 2018 | M | 1,002 | $1.67 | A | 18,013 | D | |
| Common Stock | May 2, 2018 | M | 40,000 | $22.30 | A | 58,013 | D | |
| Common StockF3,F6 | May 2, 2018 | S | 29,460 | $45.17 | D | 28,553 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $6.01 | Apr 30, 2018 | M | 1,579 | D | — | Dec 22, 2024 | Common Stock | 1,579 | 46,385 | D |
| Employee Stock Option (right to buy)F1 | $6.01 | Apr 30, 2018 | M | 705 | D | — | Dec 22, 2024 | Common Stock | 705 | 45,680 | D |
| Employee Stock Option (right to buy)F2 | $22.30 | Apr 30, 2018 | M | 6,264 | D | — | Mar 3, 2027 | Common Stock | 6,264 | 164,556 | D |
| Employee Stock Option (right to buy)F5 | $1.67 | May 2, 2018 | M | 1,002 | D | — | Dec 11, 2023 | Common Stock | 1,002 | 14,018 | D |
| Employee Stock Option (right to buy)F2 | $22.30 | May 2, 2018 | M | 40,000 | D | — | Mar 3, 2027 | Common Stock | 40,000 | 124,556 | D |
Explanation of responses
- F1The option vests as to 25% of the shares on December 22, 2015. The remainder of the shares vest in 36 equal monthly installments thereafter.
- F2The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.
- F3The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on September 14, 2017.
- F4Represents the weighted average price of transactions ranging from $42.35 to $43.00. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5The option vests as to 25% of the shares on December 11, 2014. The remainder of the shares vest in 36 equal monthly installments thereafter.
- F6Represents the weighted average price of transactions ranging from $44.00 to $45.95. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.